Rush to treat liver patients causing more harm than good

December 11, 2017 by David Lewis, University of Leeds
Rush to treat liver patients causing more harm than good
Credit: University of Leeds

Doctors risk overdiagnosing the most common and fastest-growing liver condition, exposing patients to harmful tests, according to a study published today.

It is estimated that one in four in the world is suffering from non-alcoholic (NAFLD), and there are concerns it could lead to cirrhosis.

Expert bodies in Europe are now calling for patients to be screened for the condition and the National Institute for Health and Care Excellence (NICE) in the UK has issued guidance to doctors indicating that at-risk groups should be tested.

But Dr Ian Rowe, specialist and academic fellow at the University of Leeds, in an article in The Lancet Gastroenterology and Hepatology, argued that the rush to identify the disease is not supported by the findings of published medical research.

He said the benefits of were unknown – and no licensed drug treatments were available to people who have NAFLD.

Dr Rowe said: "The case for screening is unproven – and the overwhelming published evidence suggests that the vast majority of people who have NAFLD live with the condition without it impacting on their health.

"For doctors to push for screening in those circumstances will lead to overdiagnosis, and it's known that overdiagnosis can be harmful because it exposes people to unnecessary investigations and treatments – they become labelled with a condition, and it adds to the costs of healthcare."

A new condition

The liver is the second largest organ in the body and, among other complex functions, it plays a central role in fighting infections and illness.

A healthy liver should contain little or no fat. It has been known for a long time that drinking too much alcohol causes fat to develop in the liver.

But in the mid-1980s, doctors began to find that in some people, fat build-up was happening in the absence of alcohol. The condition non-alcoholic fatty liver disease (NAFLD) was coined and is more likely in people who are overweight, obese, have type 2 diabetes or .

It can lead to inflammation and scarring of the liver and cirrhosis, a serious and life-threatening condition. But those take years to develop and only occur in a small minority of people with NAFLD.

Uncertain science

In his review of the published scientific evidence, Dr Rowe said there had been a small number of studies that suggested NAFLD was an aggressive condition that increases the risk of progressive liver disease.

But he added that those studies were open to critique because of the small number of patients tracked and possible bias in the way they were selected for investigation, factors which have overstated the threat the disease poses and created a "...heightened anxiety around the need to diagnose NAFLD".

For patients with NAFLD, the main causes of death are heart disease and cancer.

Evidence of over diagnosis

Dr Rowe said data for England shows that in 2016, 66,276 people were admitted to hospital with NAFLD listed as one of the reasons why – a 27-fold increase on the figure for 2001.

But for the same period, the number of deaths where NAFLD was listed as the primary cause went from 165 to 412 – only a threefold increase.

Dr Rowe said that since only a of patients with NAFLD will suffer complications linked to the condition, this made real the risk that people were undergoing unnecessary invasive investigations – including liver biopsy, where a small sample of the liver is removed.

He said for screening to be introduced, research was needed to identify the benefits and harms of early diagnosis, to understand the impact that diagnosis might have on and the public.

Explore further: Family of patients with NAFLD and cirrhosis are at increased risk of liver fibrosis

Related Stories

Family of patients with NAFLD and cirrhosis are at increased risk of liver fibrosis

June 19, 2017
Non-alcoholic fatty liver disease (NAFLD) is a common disorder characterized by abnormal accumulation of fat in the liver. NAFLD is diagnosed in up to one in three adults and one in 10 children in the United States, and obesity ...

Waist not weight—the key to non-alcoholic fatty liver disease

April 16, 2016
A new study presented today demonstrates that a build-up of fat around the waist can cause more serious complications than obesity in the development of non-alcoholic fatty liver disease (NAFLD). The study was presented at ...

Guidelines updated for diagnosis, management of NAFLD

July 19, 2017
(HealthDay)—A practice guidance statement, published online July 17 in Hepatology, has been developed to augment the clinical practice guidelines for the diagnosis and management of non-alcoholic fatty liver disease (NAFLD).

Nonalcoholic fatty liver disease increases risk of liver, colorectal, and breast cancers

November 13, 2017
Nonalcoholic fatty liver disease (NAFLD) is one of the more common chronic liver diseases worldwide. It is associated with metabolic syndrome (i.e. insulin resistance and diabetes) and predisposes to cardiovascular disease. ...

NASH associated with a 50 percent higher chance of death compared with NAFLD

April 24, 2015
Results from a large population-based cohort of almost a million people in the UK found that the chances of dying from non-alcoholic steatohepatitis (NASH), over a 14-year period, was approximately 50% higher than for those ...

Many diabetics don't know they have serious liver disease

September 21, 2015
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western world. NAFLD is a frequent finding in patients with type 2 diabetes, but the exact prevalence of NAFLD, as well as whether patients ...

Recommended for you

New method may allow country-level real-time surveillance of drug-resistant tuberculosis

August 21, 2018
Global tuberculosis control and elimination will require detailed real-time information on the location of individuals with the disease, the presence of drug resistance, and the patterns of transmission. The surveys currently ...

Lower-risk malaria regions are breeding grounds for drug-resistant strains

August 21, 2018
New drug-resistant strains of the parasite that causes malaria tend to evolve in regions with a lower risk of malaria. This is because in hard-hit areas with high transmission rates, like sub-Saharan Africa, they get outcompeted ...

Clay fights MRSA, other superbugs in wounds

August 21, 2018
The use of mud or wet clay as a topical skin treatment, or poultice, is a common practice in many cultures. In fact, the concept of using mud as medicine goes back to the earliest times.

Study shows children with multidrug-resistant tuberculosis can be treated

August 21, 2018
The results of a large, international systematic review published in the journal PLOS Medicine show that tuberculosis treatment is successful in children with multidrug-resistant tuberculosis (MDR-TB). The study was used ...

Largest oral HPV study in England shows infection rates lower than expected

August 20, 2018
Infection rates of high risk human papillomavirus (HR-HPV) oral infection in England are lower than expected, compared to previous US studies.

Tibetan sheep highly susceptible to human plague, originates from marmots

August 16, 2018
In the Qinghai-Tibet plateau, one of the region's highest risk areas for human plague, Himalayan marmots are the primary carriers of the infectious bacterium Y. pestis. Y. pestis infection can be transmitted to humans and ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.